View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
May 18, 2011

Chinese Hospital to Offer NeoStem Arthroscopic Orthopaedic Treatment

Nankai Hospital in Tianjin, China, is to offer NeoStem's adult stem cell treatment to patients suffering from arthritis and orthopaedic conditions. "Offering NeoStem's licensed technology in our hospital means patients with orthopaedic and arthritic conditions have the advantage of usi

By cms admin

Nankai Hospital in Tianjin, China, is to offer NeoStem’s adult stem cell treatment to patients suffering from arthritis and orthopaedic conditions.

“Offering NeoStem’s licensed technology in our hospital means patients with orthopaedic and arthritic conditions have the advantage of using their body’s own cells for self-regeneration,” said Nankai Hospital president Dr Li Ping.

NeoStem is an international biopharmaceutical company with product and service revenues, global research and development capabilities.

Around 88 of the total 1,100 patient beds at the hospital are allocated to orthopaedic patients. Following the completion of a new hospital building, the number of orthopaedic beds is expected to rise to 1,000.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management